|
|
Volumn 2, Issue 2, 2000, Pages 171-174
|
|
Autoimmune inner ear disease.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CORTICOSTEROID;
CYCLOPHOSPHAMIDE;
METHOTREXATE;
ANIMAL;
AUTOIMMUNE DISEASE;
FEMALE;
HOSPITALIZATION;
HUMAN;
IMMUNOLOGY;
INNER EAR DISEASE;
MALE;
METHODOLOGY;
MOUSE;
PERCEPTION DEAFNESS;
PLASMAPHERESIS;
PROGNOSIS;
REVIEW;
RISK ASSESSMENT;
TREATMENT OUTCOME;
ADRENAL CORTEX HORMONES;
ANIMALS;
AUTOIMMUNE DISEASES;
CYCLOPHOSPHAMIDE;
FEMALE;
HEARING LOSS, SENSORINEURAL;
HUMANS;
LABYRINTH DISEASES;
MALE;
METHOTREXATE;
MICE;
PLASMAPHERESIS;
PROGNOSIS;
RISK ASSESSMENT;
SEVERITY OF ILLNESS INDEX;
TREATMENT OUTCOME;
|
|
EID: 0034172564
PISSN: 15233774
EISSN: None
Source Type: Journal
DOI: 10.1007/s11926-000-0058-y Document Type: Review |
|
Times cited : (18)
|
|
References (25)
|
